Literature DB >> 19550400

Expression of cathepsin L in nasopharyngeal carcinoma and its clinical significance.

X Xu1, G Yuan, W Liu, Y Zhang, W Chen.   

Abstract

AIM: To study the expression of cathepsin L in nasopharyngeal carcinoma (NPC), and analyze its relationship with clinicopathologic factors.
METHODS: The expression of cathepsin L was determined immunohistochemically in NPC, adjacent normal nasopharyngeal tissues and metastatic cervical lymph nodes. The correlation between its protein expression and clinicopathologic parameters as well as with long term follow-up data in NPC was analyzed.
RESULTS: The protein of cathepsin L was overexpressed in 47% primary tumor tissues, and in 89% metastatic cervical lymph node samples. Overexpression of cathepsin L was found to correlate with lymph node metastasis ( P = 0.04) and distant metastasis ( P = 0.01), and marginally with clinical stage and T classification, but not with patient age, gender and histological classification of tumor. Patients with overexpression of cathepsin L in tumor tissue had worse 5-year survival than those without such expression pattern ( P = 0.033). Multivariate survival analysis showed that cathepsin L protein expression level had a marginal significant correlation with prognosis of NPC.
CONCLUSION: Cathepsin L is a potential biomarker for prognosis of NPC and contributes to NPC metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19550400

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  10 in total

Review 1.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

2.  Cathepsin L inactivation leads to multimodal inhibition of prostate cancer cell dissemination in a preclinical bone metastasis model.

Authors:  Dhivya R Sudhan; Christine Pampo; Lori Rice; Dietmar W Siemann
Journal:  Int J Cancer       Date:  2016-02-05       Impact factor: 7.396

3.  Expression of stefin A is of prognostic significance in squamous cell carcinoma of the head and neck.

Authors:  Aleksandar Aničin; Nina Gale; Lojze Smid; Janko Kos; Primož Strojan
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-02       Impact factor: 2.503

4.  Plasma cathepsin L: a prognostic marker for pancreatic cancer.

Authors:  Nidhi Singh; Prasenjit Das; Surabhi Gupta; Vikas Sachdev; Siddhartha Srivasatava; Siddhartha Datta Gupta; Ravindra Mohan Pandey; Peush Sahni; Shyam S Chauhan; Anoop Saraya
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

5.  Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas.

Authors:  Chih-Ching Wu; Chia-Wei Hsu; Chi-De Chen; Chia-Jung Yu; Kai-Ping Chang; Dar-In Tai; Hao-Ping Liu; Wen-Hui Su; Yu-Sun Chang; Jau-Song Yu
Journal:  Mol Cell Proteomics       Date:  2010-02-01       Impact factor: 5.911

6.  Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms.

Authors:  Adeyemi O Adedeji; William Severson; Colleen Jonsson; Kamalendra Singh; Susan R Weiss; Stefan G Sarafianos
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

7.  Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblasts.

Authors:  Shenglei Ge; Yitao Mao; Yan Yi; Dinghua Xie; Zhuchu Chen; Zhiqiang Xiao
Journal:  Exp Ther Med       Date:  2012-02-13       Impact factor: 2.447

Review 8.  Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.

Authors:  Amit Walia; Jessica F Yang; Yu-Hui Huang; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Biochim Biophys Acta       Date:  2015-09-12

9.  Increased expression of cathepsin L: a novel independent prognostic marker of worse outcome in hepatocellular carcinoma patients.

Authors:  Jian Ruan; Hang Zheng; Wenguang Fu; Peng Zhao; Ning Su; Rongcheng Luo
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

10.  miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA.

Authors:  Shujuan Ni; Weiwei Weng; Midie Xu; Qifeng Wang; Cong Tan; Hui Sun; Lei Wang; Dan Huang; Xiang Du; Weiqi Sheng
Journal:  Onco Targets Ther       Date:  2018-07-04       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.